BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 10779358)

  • 21. ARF6 targets recycling vesicles to the plasma membrane: insights from an ultrastructural investigation.
    D'Souza-Schorey C; van Donselaar E; Hsu VW; Yang C; Stahl PD; Peters PJ
    J Cell Biol; 1998 Feb; 140(3):603-16. PubMed ID: 9456320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ARAP2 effects on the actin cytoskeleton are dependent on Arf6-specific GTPase-activating-protein activity and binding to RhoA-GTP.
    Yoon HY; Miura K; Cuthbert EJ; Davis KK; Ahvazi B; Casanova JE; Randazzo PA
    J Cell Sci; 2006 Nov; 119(Pt 22):4650-66. PubMed ID: 17077126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Actin assembly at membranes controlled by ARF6.
    Schafer DA; D'Souza-Schorey C; Cooper JA
    Traffic; 2000 Nov; 1(11):892-903. PubMed ID: 11273133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endosomal trafficking of the receptor tyrosine kinase MuSK proceeds via clathrin-dependent pathways, Arf6 and actin.
    Luiskandl S; Woller B; Schlauf M; Schmid JA; Herbst R
    FEBS J; 2013 Jul; 280(14):3281-97. PubMed ID: 23621612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GEP100/BRAG2: activator of ADP-ribosylation factor 6 for regulation of cell adhesion and actin cytoskeleton via E-cadherin and alpha-catenin.
    Hiroi T; Someya A; Thompson W; Moss J; Vaughan M
    Proc Natl Acad Sci U S A; 2006 Jul; 103(28):10672-7. PubMed ID: 16807291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ARAP2 signals through Arf6 and Rac1 to control focal adhesion morphology.
    Chen PW; Jian X; Yoon HY; Randazzo PA
    J Biol Chem; 2013 Feb; 288(8):5849-60. PubMed ID: 23295182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arfs, phosphoinositides and membrane traffic.
    Donaldson JG
    Biochem Soc Trans; 2005 Dec; 33(Pt 6):1276-8. PubMed ID: 16246097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exchange factor EFA6R requires C-terminal targeting to the plasma membrane to promote cytoskeletal rearrangement through the activation of ADP-ribosylation factor 6 (ARF6).
    Kanamarlapudi V
    J Biol Chem; 2014 Nov; 289(48):33378-90. PubMed ID: 25296758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vav2 activates Rac1, Cdc42, and RhoA downstream from growth factor receptors but not beta1 integrins.
    Liu BP; Burridge K
    Mol Cell Biol; 2000 Oct; 20(19):7160-9. PubMed ID: 10982832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ACAPs are arf6 GTPase-activating proteins that function in the cell periphery.
    Jackson TR; Brown FD; Nie Z; Miura K; Foroni L; Sun J; Hsu VW; Donaldson JG; Randazzo PA
    J Cell Biol; 2000 Oct; 151(3):627-38. PubMed ID: 11062263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ADP ribosylation factor 6 (Arf6) acts through FilGAP protein to down-regulate Rac protein and regulates plasma membrane blebbing.
    Kawaguchi K; Saito K; Asami H; Ohta Y
    J Biol Chem; 2014 Apr; 289(14):9675-82. PubMed ID: 24526684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Localization and regulation of phospholipase D2 by ARF6.
    Hiroyama M; Exton JH
    J Cell Biochem; 2005 May; 95(1):149-64. PubMed ID: 15759270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of nonapoptotic cell death by activated Ras requires inverse regulation of Rac1 and Arf6.
    Bhanot H; Young AM; Overmeyer JH; Maltese WA
    Mol Cancer Res; 2010 Oct; 8(10):1358-74. PubMed ID: 20713492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ADP-ribosylation factor 6 regulates mammalian myoblast fusion through phospholipase D1 and phosphatidylinositol 4,5-bisphosphate signaling pathways.
    Bach AS; Enjalbert S; Comunale F; Bodin S; Vitale N; Charrasse S; Gauthier-Rouvière C
    Mol Biol Cell; 2010 Jul; 21(14):2412-24. PubMed ID: 20505075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ADP-ribosylation factor 6 regulates glioma cell invasion through the IQ-domain GTPase-activating protein 1-Rac1-mediated pathway.
    Hu B; Shi B; Jarzynka MJ; Yiin JJ; D'Souza-Schorey C; Cheng SY
    Cancer Res; 2009 Feb; 69(3):794-801. PubMed ID: 19155310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Na+-H+ exchanger-1 induces cytoskeletal changes involving reciprocal RhoA and Rac1 signaling, resulting in motility and invasion in MDA-MB-435 cells.
    Paradiso A; Cardone RA; Bellizzi A; Bagorda A; Guerra L; Tommasino M; Casavola V; Reshkin SJ
    Breast Cancer Res; 2004; 6(6):R616-28. PubMed ID: 15535843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Remodeling of the actin cytoskeleton is coordinately regulated by protein kinase C and the ADP-ribosylation factor nucleotide exchange factor ARNO.
    Frank SR; Hatfield JC; Casanova JE
    Mol Biol Cell; 1998 Nov; 9(11):3133-46. PubMed ID: 9802902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GEP100/Arf6 is required for epidermal growth factor-induced ERK/Rac1 signaling and cell migration in human hepatoma HepG2 cells.
    Hu Z; Du J; Yang L; Zhu Y; Yang Y; Zheng D; Someya A; Gu L; Lu X
    PLoS One; 2012; 7(6):e38777. PubMed ID: 22701712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Actin-mediated gene expression depends on RhoA and Rac1 signaling in proximal tubular epithelial cells.
    Giehl K; Keller C; Muehlich S; Goppelt-Struebe M
    PLoS One; 2015; 10(3):e0121589. PubMed ID: 25816094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro and in vivo analysis of neurotrophin-3 activation of Arf6 and Rac-1.
    Esteban PF; Caprari P; Yoon HY; Randazzo PA; Tessarollo L
    Methods Enzymol; 2008; 438():171-83. PubMed ID: 18413248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.